Mon / February 24 / 2014
Exir is FDA-registered (Food and Drug Registration) since January 2014. We have realized the registration and implemented new routines in our factory to be able to make direct deliveries to North America and fulfill the requirements for meditech equipment that are regulated by the American government.
”When the procedures and certification of ISO:13485 was accomplished it was a natural step for us to FDA-certify the company to strengthen Exir’s competitiveness on the global market. The certification will improve the efficiency of logistics within the operation and lower the costs for our costumers. Furthermore, the registration opens up new opportunities for Exir to become an even more established and global supplier of meditech products”, says Jonas Idsäter, owner of Exir.